Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Fenbendazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 8/20 | 0.82 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.82 |
| ▸ | MEN1 | O00255 | 2/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.82 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.82 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.82 |
| ▸ | KDR | P35968 | 5/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fenbendazole SCHEMBL3988034 | 1.00 | LMNA (0.82) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| Fenbendazole SCHEMBL31547342 | 1.00 | LMNA (0.82) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| Fenbendazole SCHEMBL31547327 | 1.00 | LMNA (0.82) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| Fenbendazole SCHEMBL9639071 | 0.99 | LMNA (0.80) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| Fenbendazole SCHEMBL28228589 | 0.99 | LMNA (0.80) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| Fenbendazole SCHEMBL845544 | 0.96 | LMNA (0.81) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| Fenbendazole SCHEMBL28193035 | 0.95 | LMNA (0.76) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| Fenbendazole SCHEMBL4981601 | 0.91 | LMNA (0.70) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| SCHEMBL24359625 | 0.90 | LMNA (0.67) | LMNACYP1A2MEN1KMT2ANR1I2 | |
| Fenbendazole SCHEMBL8469702 | 0.90 | LMNA (1.00) | LMNACYP1A2MEN1KMT2ANR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7781 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122039076-A | Preparation method of 2-methyl sulfoxide pyrimidine derivative | 石河子大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260097100-A1 | CANCER TREATMENT BY INDUCTION OF TUMOR AND STEM CELL DIFFERENTIATION | LATHAM KEITH ROGER (US) | 2026-04-09 | — | — | US | claimed |
| WO-2026044269-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING ALZHEIMER'S DISEASE AND OTHER | SAFWAT SHERIF (US) | 2026-02-26 | — | — | WO | claimed |
| EP-4687480-A2 | MATERIALS AND METHODS FOR THE MANUFACTURE OF AN ANIMAL FEED | In the Bowl Animal Health, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260026529-A1 | MATERIALS AND METHODS FOR THE MANUFACTURE OF AN ANIMAL FEED | IN THE BOWL ANIMAL HEALTH INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4680240-A1 | METHOD OF TREATING DISORDERS WITH SURF1 MALFUNCTION | Cure Mito Foundation (US) | 2026-01-21 | — | — | EP | claimed |
| US-12496374-B2 | Deodorizer composition, absorbing body, and absorbent article | SUMITOMO SEIKA CHEMICALS CO, LTD. (JP) | 2025-12-16 | — | — | US | claimed |
| US-20250352518-A1 | A BENZIMIDAZOLE COMPOUND WITH ANTIHELMINTHIC ACTIVITY FOR USE IN REVERSING, ARRESTING OR SLOWING DOWN CELLULAR AGEING IN A VERTEBRATE SUBJECT | RAVAN BIO LIMITED (GB) | 2025-11-20 | — | — | US | claimed |
| US-12465623-B2 | Use of parasites and extracellular vesicles obtained from parasites in cancer treatment | YEDITEPE UNIVERSITESI (TR) | 2025-11-11 | — | — | US | claimed |
| US-20250333775-A1 | DIAGNOSTIC TEST AND THERAPY FOR PATIENTS WITH AUTO-BREWERY SYNDROME | UNIV CALIFORNIA (US) | 2025-10-30 | — | — | US | claimed |
| EP-0146573-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTHELMINTIC ACTIVITY, DOSAGE UNITS THEREOF AND METHOD FOR TREATING HELMINTHIASIS IN ANIMALS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-07-03 | — | — | EP | claimed |
| WO-1984004677-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTHELMINTIC ACTIVITY, DOSAGE UNITS THEREOF AND METHOD FOR TREATING HELMINTHIASIS IN ANIMALS | HOECHST AG (DE) | 1984-12-06 | — | — | WO | claimed |
| WO-1984004455-A1 | POTENTIATION OF ANTHELMINTICS | COMMW SCIENT IND RES ORG (AU) | 1984-11-22 | — | — | WO | claimed |
| EP-0060810-B1 | ANTHELMINTICS | CIBA-GEIGY AG (CH) | 1984-10-17 | — | — | EP | claimed |
| EP-0059074-B1 | ANTHELMINTIC COMPOSITION AND THE USE THEREOF | SANKYO COMPANY LIMITED (JP) | 1984-10-10 | — | — | EP | claimed |
| US-4468390-A | Anthelmintic composition and the use thereof | SANKYO COMPANY, LIMITED (JP) | 1984-08-28 | — | — | US | claimed |
| EP-0025696-B1 | CONTROLLED RELEASE PARASITICIDAL FORMULATIONS | ELI LILLY AND COMPANY (US) | 1984-04-04 | — | — | EP | claimed |
| EP-0090368-A1 | Anthelmintic preparations | HOECHST UK LIMITED (GB) | 1983-10-05 | — | — | EP | claimed |
| EP-0059074-A1 | Anthelmintic composition and the use thereof | SANKYO COMPANY LIMITED (JP) | 1982-09-01 | — | — | EP | claimed |
| EP-0025696-A2 | Controlled release parasiticidal formulations | ELI LILLY AND COMPANY (US) | 1981-03-25 | — | — | EP | claimed |